KRas Induces a Src/PEAK1/ErbB2 Kinase Amplification Loop That Drives Metastatic Growth and Therapy Resistance in Pancreatic Cancer

Early biomarkers and effective therapeutic strategies are desperately needed to treat pancreatic ductal adenocarcinoma (PDAC), which has a dismal 5-year patient survival rate. Here, we report that the novel tyrosine kinase PEAK1 is upregulated in human malignancies, including human PDACs and pancrea...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kelber, Jonathan A., Reno, Theresa, Kaushal, Sharmeela, Metildi, Cristina, Wright, Tracy, Stoletov, Konstantin, Weems, Jessica M., Park, Frederick D., Mose, Evangeline, Wang, Yingchun, Hoffman, Robert M., Lowy, Andrew M., Bouvet, Michael, Klemke, Richard L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366503/
https://ncbi.nlm.nih.gov/pubmed/22589274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-3552
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky